Sort   by:  
 Page size 
UnknownPolymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.
Not available
S-EPMC4572510 | biostudies-literature
UnknownAssessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Not available
S-EPMC4374346 | biostudies-literature
UnknownIdentification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
Not available
S-EPMC4334820 | biostudies-literature
UnknownCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
Not available
S-EPMC4204770 | biostudies-literature
Unknown2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.
Not available
S-EPMC4082638 | biostudies-literature
UnknownAn intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.
Not available
S-EPMC5216618 | biostudies-literature
UnknownCommon variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
Not available
S-EPMC4635670 | biostudies-literature
UnknownFine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Not available
S-EPMC4406292 | biostudies-literature
UnknownBridging big data in the ENIGMA consortium to combine non-equivalent cognitive measures.
Not available
S-EPMC11484938 | biostudies-literature
UnknownGWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
Not available
S-EPMC3693183 | biostudies-literature
Sort   by:  
 Page size